Press Releases

2019 Financial Results

€2,675 million in sales for full-year 2019, representing a reported increase of 10.5% and organic growth of 7.2% Strong sales momentum in the fourth quarter, with organic growth of 8.3% driven by sale...

Financial Information

Résultats annuels au 31 décembre 2019

Chiffre d’affaires 2019 de 2 675 millions d’euros, en hausse de 10,5 % à données publiées, soit une croissance organique de 7,2 % Solide dynamique commerciale au 4e trimestre, avec une croissance orga...

bioMérieux submits enhanced BIOFIRE® BCID2 Panel for FDA clearance

bioMérieux, a world leader in the field of in vitro diagnostics, announces that BioFire Diagnostics, its molecular biology affiliate, has submitted to the Food and Drug Administration for 510(k) clear...

bioMérieux and the Fleming Fund: working together to strengthen diagnostic capacity and tackle antimicrobial resistance in low- and middle-income countries

London (UK), Marcy l’Étoile (France) – December 18, 2019 – bioMérieux, a world leader in in vitro diagnostics which develops and manufactures testing solutions (systems, reagents, software, services) ...

Third-Quarter 2019 Business Review

Organic growth of 6.8% at constant exchange rates and scope of consolidation over the first nine months of the year: €1,928 million in sales Up 10.3% as reported Acceleration of organic growth in sale...

First-Half 2019 Results

bioMérieux – First-Half 2019 Results Organic sales growth of 5.5% for first-half 2019: €1,275 million in sales Up 9.1% as reported As expected, growth accelerated in the second quarter, up to 7.4% at ...